Monday, March 12, 2007

Interview with HealthSonix CEO Michael Ivezic (HSXI)

(HSXI)

Clinical Results

To objectively monitor pre and post response to the Arthritis Treatment Centers treatments, patients are requested to complete the WOMAC (lower extremities) or DASH (upper extremities) questionnaires, which probe for clinically important, patient-relevant symptoms in the areas of pain, stiffness and physical function.

The WOMAC instrument is one of two recognized by the FDA for use in all arthritis clinical research studies. Arthritis Treatment Centers has made WOMAC assessments a standard practice in the centers' daily operations.

After the baseline arthritis index is created, patient-specific treatment goals are defined. This helps the patient visualize their progress and allows treatment centers professionals to standardize patient progress reports to referring doctors. The WOMAC reports also give our clinicians valuable feedback and are a key to refining the ongoing longer-term treatment protocols and exercise programs.

From 385 patients who completed the basic course of 10 treatments sessions, the documented results in the Toronto clinic were as follows:
http://healthsonix.com/science-clinical-results.php

Recent News
HealthSonix Update to Shareholders
Market Wire (Mon, Mar 5)

MoneyTV, Week of 3/2
Market Wire (Fri, Mar 2)

HealthSonix CEO Webcast With TheGreenBaron.com Now Available Online
Market Wire (Mon, Feb 26)

MoneyTV, Week of 2/23
Market Wire (Fri, Feb 23)

HealthSonix CEO to Be Interviewed Live on MN1.com
Market Wire (Thu, Feb 22)

HealthSonix Invited to Present at Small Cap Expo in New York City
Market Wire (Tue, Feb 20)

HealthSonix Appoints CMI as Exclusive Distributor in South Korea for Its Medical Devices
Market Wire (Tue, Jan 9)

HealthSonix' Research Study Shows Clinically Significant Pain Reduction With Osteoarthritis Patients
Market Wire (Wed, Dec 13)

HealthSonix's AquaSonix Therapy Now Available at Two More State-of-the-Art Healthcare Facilities
Market Wire (Mon, Nov 20)

HealthSonix Commences New Clinical Trials to Expand Medical Claims for AquaSonix Therapy
Market Wire (Thu, Nov 9)
More Headlines for HSXI.PK...

No comments:

Post a Comment

Your comment will be posted within 1 hour of acceptance by our editorial staff.